Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 13, 2024
Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma
Marta Mendiola, Jani Saarela, Francisco Javier Escudero, et al.
Aging Cell
|
October 20, 2023
Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitors
Angela Rizzo, Carmen Maresca, Carmen D'Angelo, et al.
Frontiers in Oncology
|
September 9, 2022
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status
Pia Roering, Arafat Siddiqui, Vanina D Heuser, et al.
Leukemia
|
November 10, 2020
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets
Shady Adnan-Awad, Daehong Kim, Helena Hohtari, et al.
The Journal of Pathology
|
October 10, 2019
ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors
Katja Kaipio, Ping Chen, Pia Roering, et al.
Nature Protocols
|
November 23, 2023
Robust scoring of selective drug responses for patient-tailored therapy selection
Yingjia Chen, Liye He, Aleksandr Ianevski, et al.
NPJ Precision Oncology
|
April 25, 2025
Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma
Ruth Nousiainen, Katja Eloranta, Jani Saarela, et al.
Cancers
|
July 2, 2021
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome
Maral Jamshidi, Rainer Fagerholm, Taru A Muranen, et al.
Antiviral Research
|
January 25, 2024
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome
Mariia S Bogacheva, Suvi Kuivanen, Swapnil Potdar, et al.
British Journal of Cancer
|
February 13, 2019
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
Bertha A Brodin, Krister Wennerberg, Elisabet Lidbrink, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 13, 2024
Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma
Marta Mendiola, Jani Saarela, Francisco Javier Escudero, et al.
Aging Cell
|
October 20, 2023
Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitors
Angela Rizzo, Carmen Maresca, Carmen D'Angelo, et al.
Frontiers in Oncology
|
September 9, 2022
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status
Pia Roering, Arafat Siddiqui, Vanina D Heuser, et al.
Leukemia
|
November 10, 2020
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets
Shady Adnan-Awad, Daehong Kim, Helena Hohtari, et al.
The Journal of Pathology
|
October 10, 2019
ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors
Katja Kaipio, Ping Chen, Pia Roering, et al.
Nature Protocols
|
November 23, 2023
Robust scoring of selective drug responses for patient-tailored therapy selection
Yingjia Chen, Liye He, Aleksandr Ianevski, et al.
NPJ Precision Oncology
|
April 25, 2025
Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma
Ruth Nousiainen, Katja Eloranta, Jani Saarela, et al.
Cancers
|
July 2, 2021
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome
Maral Jamshidi, Rainer Fagerholm, Taru A Muranen, et al.
Antiviral Research
|
January 25, 2024
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome
Mariia S Bogacheva, Suvi Kuivanen, Swapnil Potdar, et al.
British Journal of Cancer
|
February 13, 2019
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
Bertha A Brodin, Krister Wennerberg, Elisabet Lidbrink, et al.
Page
of 4